Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Bulgaria

Bulgaria Articles

Industry

BMI View: The news that drugmakers have shunned efforts to discount medicine prices and that the National Health Insurance Fund (NHIF) has been paying significantly higher prices for... 2012-11-09


Industry

BMI View: The Bulgarian Competition Protection Commission (CPC)'s criticism of the National Health Insurance Fund (NHIF)'s pricing and reimbursement rules is unlikely to discourage... 2012-07-09


Industry

BMI View: While the recently appointed new heads at the Bulgarian Ministry of Health and the National Health Insurance Fund (NHIF) are now clearly looking at more aggressive mechanisms... 2012-05-03


More ARTICLES

Industry

BMI View: Bulgaria's public healthcare system remains underfunded. Short-term measures to reduce non-payment of medical insurance may seem encouraging but with the central government... 2012-05-02


Industry

BMI View: with a few exceptions, the attractiveness of Central And Eastern European (CEE) pharmaceutical markets has remained relatively stable in our Q312 Risk/Reward Ratings (RRRs)... 2012-04-05


Industry

BMI View: Our view that any appointment as Bulgaria's Minister of Health would be under equal pressure as their predecessor to reduce the prices of reimbursed medicines continues to... 2012-04-02


Industry

BMI View: The resignation of Bulgarian minister of health Stefan Konstantinov remains in line with our core scenario for this market and we maintain our previously stated view that... 2012-03-20


Industry

BMI View: Governments across Central Europe have been quick to introduce drug policy reforms that aim to reduce pharmaceutical expenditure and shift the financial burden on to patients... 2012-03-12

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries